Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 26 to 50 of 132

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Dupilumab for treating severe asthma with type 2 inflammationTA751
Durvalumab for maintenance treatment of unresectable non-small-cell lung cancer after platinum-based chemoradiationTA798
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodulesDG46
Elosulfase alfa for treating mucopolysaccharidosis type 4AHST19
Empagliflozin for treating chronic heart failure with reduced ejection fractionTA773
Endo-SPONGE for treating low rectal anastomotic leakMTG63
Endoanchoring systems in endovascular aortic aneurysm repairIPG725
Endobronchial nerve ablation for chronic obstructive pulmonary diseaseIPG714
Endoscopic balloon dilation for subglottic or tracheal stenosisIPG719
Endoscopic full thickness removal of gastrointestinal stromal tumours of the stomachIPG717
Enfortumab vedotin for previously treated locally advanced or metastatic urothelial cancer (terminated appraisal)TA797
Epilepsies in children, young people and adultsNG217
Faricimab for treating diabetic macular oedemaTA799
Faricimab for treating wet age-related macular degenerationTA800
Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosisTA756
Fetal alcohol spectrum disorderQS204
Filgotinib for treating moderately to severely active ulcerative colitisTA792
Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment)DG47
FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndromeMIB281
Fremanezumab for preventing migraineTA764
Glaucoma: diagnosis and managementNG81
Gout: diagnosis and managementNG219
Granulox for managing chronic non-healing woundsMIB296
Headaches in over 12s: diagnosis and managementCG150
Ibrutinib for treating Waldenstrom's macroglobulinaemiaTA795

Results per page

  1. 10
  2. 25
  3. 50
  4. All